Apr 5, 2024 · "CARVYKTI demonstrated remarkable efficacy as a personalized, one-time infusion in the earlier treatment of relapsed/refractory multiple myeloma as shown ...

Apr 5, 2024 · Antibody-Drug Conjugates: Delivering Cancer-Killing Medicines Directly to Tumors. ADCs have become a promising class of targeted therapy designed to bind to a ...

Apr 17, 2024 · We are active in the chiropractic, physical therapy, sports medicine and veterinary markets and growing rapidly within these markets and into new ones.

Apr 16, 2024 · Background. Current evidence concerning bowel preparation before elective colorectal surgery is still controversial. This study aimed to compare the ...

5 days ago · However, due to limited research, no standard treatment regimen exists for PCNSL. Retrospective studies indicate that radiotherapy and chemotherapy extend ...

Apr 17, 2024 · Innovative clinical trials that evaluate multiple treatments simultaneously and intended to continue beyond the evaluation of any one treatment, while ...

Apr 5, 2024 · Multiple myeloma is an incurable and progressive hematologic cancer that causes patients to relapse and become refractory to treatment, so new, innovative ...

Apr 11, 2024 · When bacteria or fungi become resistant to multiple antibiotics, they are referred to as multidrug-resistant organisms (MDROs) and often have very limited ...

Apr 9, 2024 · The FDA approved expanded use of Abecma for adults with hard-to-treat multiple myeloma; it can now be taken earlier in the treatment regimen.